Maurizio Voi

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

Anthem Insurance Cos., Inc. provides health insurance plans, group life, insurance brokerage and other related services. It offers a range of administrative, managed care services and partially insured products for employer self-funded plans. The firm also provides group life and disability insurance benefits, pharmacy benefit management, dental, vision and behavioral health benefits services. The company is headquartered in Indianapolis, IN.

LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.

Emmis Operating Co. provides operates radio and television broadcasting stations. Its services include radio broadcasting, television broadcasting and magazine publishing operations. The company was founded in 2001 and is headquartered in Indianapolis, IN.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Part of Takeda Pharmaceutical Co., Ltd., CytoMed, Inc. is a company that develops therapeutics for cancer treatment. The company is based in Cambridge, MA. CytoMed was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on February 12, 1999 for $19.29 million.

Blue Cross & Blue Shield Association provides healthcare insurance services. The firm operates several business initiatives in support of the Blue Cross and Blue Shield companies and represents the Blue System in national forums. It offers insurance products to all segments of the population, including large employer groups, small business and individuals. The company was founded in 1982 and is headquartered in Chicago, IL.

ACT Biotech, Inc. operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs. The company was founded on February 15, 2008 and is headquartered in New York, NY.

Melanoma Therapeutics Foundation supports and researches treatments for melanoma. It provides resources for patients and physicians, supports investigators, and provides new drug development through bridging relationships between academia, pharmaceutical and biotechnology companies. The foundation is headquartered in San Francisco, California

EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark.

Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL.

Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel.

Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA.

GreenMark Biomedical, Inc. operates as a healthcare company. It develops technologies that involve small biopolymer particles produced from food grade starch. The firm?s diagnostic product is used by dental professionals as part of the routine dental exam, assess, and monitor non-invasive treatment of dental caries. The company was founded by Steven Bloembergen in March 2016 and is headquartered in East Lansing, MI.

Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million.

Novasenta, Inc. develops therapies for cancer. The company is based in Pittsburgh, PA. The company was founded by Greg Delgoffe, Robert L. Ferris, Dario Vignali. Mani Mohindru has been the CEO of the company since 2021.